Licensing and regulatory adherence are foundational to patient safety. Agencies like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other regional authorities set standards covering drug development, manufacturing, labeling, and post-market surveillance. Licensing also ensures organizations and professionals meet ethical and operational criteria. Without a clear compliance framework, companies risk regulatory setbacks or reputational damage. Dr. Katz assists by translating these complex global requirements into practical strategies, enabling clients to balance regulatory demands while advancing therapies with confidence.